Cargando…
Cemiplimab-Associated Sinusoidal Obstruction Syndrome
A 58-year-old woman developed new-onset recurrent ascites after the recent initiation of cemiplimab for the treatment of advanced basal cell carcinoma. A comprehensive serological workup for viral, metabolic, and autoimmune causes was unrevealing. Transjugular liver biopsy demonstrated parenchymal c...
Autores principales: | Sarsour, Nadeen Y., Minervini, Marta, Malik, Shahid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118369/ https://www.ncbi.nlm.nih.gov/pubmed/37091208 http://dx.doi.org/10.14309/crj.0000000000001038 |
Ejemplares similares
-
Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure
por: Shah, Urvi A., et al.
Publicado: (2018) -
Busulfan: Sinusoidal obstruction syndrome with thrombotic microangiopathy: case report
Publicado: (2021) -
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
por: Denis, Chloé, et al.
Publicado: (2021) -
Intravascular squamous cell carcinoma treated with cemiplimab
por: Rose, Alexander N., et al.
Publicado: (2021) -
Dactinomycin-induced Hepatic Sinusoidal Obstruction Syndrome Responding to Treatment with N-acetylcysteine
por: Lee, Anselm Chi-wai, et al.
Publicado: (2011)